| Literature DB >> 29520239 |
Stefano Cinque1,2, Francesca Zoratto1, Anna Poleggi2, Damiana Leo3, Luca Cerniglia4, Silvia Cimino5, Renata Tambelli5, Enrico Alleva1, Raul R Gainetdinov6,7, Giovanni Laviola1, Walter Adriani1,4.
Abstract
Alterations in dopamine neurotransmission are generally associated with diseases such as attention-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). Such diseases typically feature poor decision making and lack of control on executive functions and have been studied through the years using many animal models. Dopamine transporter (DAT) knockout (KO) and heterozygous (HET) mice, in particular, have been widely used to study ADHD. Recently, a strain of DAT KO rats has been developed (1). Here, we provide a phenotypic characterization of reward sensitivity and compulsive choice by adult rats born from DAT-HET dams bred with DAT-HET males, in order to further validate DAT KO rats as an animal model for preclinical research. We first tested DAT KO rats' sensitivity to rewarding stimuli, provided by highly appetitive food or sweet water; then, we tested their choice behavior with an Intolerance-to-Delay Task (IDT). During these tests, DAT KO rats appeared less sensitive to rewarding stimuli than wild-type (WT) and HET rats: they also showed a prominent hyperactive behavior with a rigid choice pattern and a wide number of compulsive stereotypies. Moreover, during the IDT, we tested the effects of amphetamine (AMPH) and RO-5203648, a trace amine-associated receptor 1 (TAAR1) partial agonist. AMPH accentuated impulsive behaviors in WT and HET rats, while it had no effect in DAT KO rats. Finally, we measured the levels of tyrosine hydroxylase, dopamine receptor 2 (D2), serotonin transporter, and TAAR1 mRNA transcripts in samples of ventral striatum, finding no significant differences between WT and KO genotypes. Throughout this study, DAT KO rats showed alterations in decision-making processes and in motivational states, as well as prominent motor and oral stereotypies: more studies are warranted to fully characterize and efficiently use them in preclinical research.Entities:
Keywords: Intolerance-to-Delay Task; appetitive food eating; behavioral rigidity; reward sensitivity; sucrose consumption
Year: 2018 PMID: 29520239 PMCID: PMC5826953 DOI: 10.3389/fpsyt.2018.00043
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Figure 1The average body weight measured for the three genotypes. Knockout (KO) rats weigh significantly less when compared to both wild-type (WT) and dopamine transporter–heterozygous (HET) rats. *P < 0.0001.
Figure 2Proportion of the fluid intake from a bottle containing 14% sucrose over tap water. Preference for the sucrose bottle is significantly lower for knockout (KO) rats when compared to both wild-type (WT) and dopamine transporter–heterozygous (HET) rats. *P < 0.0001.
Figure 3Percentage preference for a large-and-late (LL) reward over a small-and-soon (SS) one in an operant Intolerance-to-Delay Task. (A) Preference for LL at increasing delays after the administration of different drugs. Whereas preference for LL decreases significantly at higher delays, knockout (KO) rats show a significantly higher preference for LL when compared to both wild-type (WT) and dopamine transporter–heterozygous (HET) rats. Amphetamine (AMPH) reduces significantly LL preference in WT rats at all three delays. *P < 0.05. (B) The effect of the different drugs on LL preference (average value collapsed across delays). WT rats, after AMPH administration, show a significantly reduced LL preference compared to the saline, vehicle, and RO-5203648 groups. **P < 0.0001.
Figure 4Other parameters from the Intolerance-to-Delay Task. (A) Total small-and-soon (SS) trials at increasing delays. While there is a clear increase of the number of SS trials at higher delays in wild-type (WT) and dopamine transporter (DAT)–heterozygous (HET) rats, knockout (KO) rats did not show such an increase. **P < 0.0001. (B) The effect of the different drugs on the total SS trials. The administration of amphetamine (AMPH) on WT and DAT–HET rats has a significant effect to increase the total SS trials, if compared to saline, vehicle, and RO-5203648. *P < 0.05. (C) Total [SS + large-and-late (LL)] trials performed at all the three delays: total trials of KO rats were always significantly lower than those of WT and DAT–HET rats. **P < 0.0001. (D) The total inadequate nose-pokes, performed in both nose-poking holes during the timeout (i.e., when without consequences). For WT and DAT–HET rats, the total inadequate nose-pokes significantly increase at higher delays; conversely, for KO rats, inadequate nose-pokes significantly decrease at higher delays. *P < 0.05, **P < 0.0001.
Figure 5Normalized expression rates [knockout (KO)/wild-type (WT)] of tyrosine hydroxylase (TH), trace amine-associated receptor 1 (TAAR1), serotonin transporter (Slc6a4), and dopamine receptor 2 (D2), in ventral striatum samples of rats. For each of the assayed genes, there were no significant differences in expression levels between WT and KO rats.